key: cord-0711606-ahykx0vq authors: Kumar, Mukesh; van Dellen, David; Loughton, Holly; Woywodt, Alexander title: Time to press the reset button – can we use the COVID-19 pandemic to rethink the process of transplant assessment? date: 2021-07-06 journal: Clin Kidney J DOI: 10.1093/ckj/sfab118 sha: 09fab3b6621b0688de1f43fe9581306ea14ec767 doc_id: 711606 cord_uid: ahykx0vq Coronavirus disease 2019 (COVID-19) has taken a severe toll on the transplant community with significant morbidity and mortality not just among transplant patients and those on the waiting list but also among colleagues. It is therefore not surprising that clinicians in this field have viewed the events of the last 18 months as predominantly negative. As the pandemic is gradually ebbing away we argue that this is also a unique opportunity to re-think transplant assessment. Firstly, we have witnessed a step-change in the use of technology and virtual assessments. Another effect of the pandemic is that we have had to make do with what was available - which has often worked surprisingly well. Finally, we have learned to think the unthinkable: maybe things don’t have to continue the way they have always been. As we emerge the other side of the pandemic we should rethink which parts of the transplant assessment process are necessary and evidence based. We emphasize the need to involve patients in the redesign of pathways and we argue that the assessment process could be made more transparent to patients. We describe a possible roadmap towards transplant assessment pathways that are truly fit for the 21st century. INTRODUCTION Ever since its first description, Coronavirus disease 2019 has triggered worldwide and unprecedented disruption in healthcare. The field of renal transplantation has been particularly affected and considerable mortality has been reported in recipients with COVID-19 1 . This, together with the disruption in healthcare overall, led many transplant programmes to cease listing and surgical activity for some time during 2020. As of December 2020, the pandemic has also caused significant mortality in health care workers. Not surprisingly, transplant teams have perceived the pandemic mainly as a catastrophic event with a mind-set of trying to restore transplant listing and surgical activity and return to the status quo ante. Here, we argue that transplant teams can also regard the current situation as an opportunity. We consider the pandemic as a disruptor in a positive sense i.e. a unique event that allows us to question established practice, re-focus and re-design transplant assessment and listing pathways. As a group of clinicians supported by one of our patients we propose a radical rethink of transplant assessment pathways, outline an early vision of what success might look like and discuss limitations of such an approach. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 4 Transplant assessment: The status quo and its shortcomings The fact that many aspects of transplant assessment lack a robust evidence base has been noted before. In comparison, procedural aspects of transplant listing have received much less attention. Considerable heterogeneity exists with regards to thresholds for starting transplant assessment, the extent to which patients are empowered as part of the decision making process and how this is embedded in a holistic care pathway. The amount of information and the platforms used to provide it also vary hugely. It is worth while dissecting the pathway in more detail ( Figure 1 ). Traditionally, teams still rely on paper and postal system for the communication process. In our instituion, a straightforward transplant candidate may thus accumulate around 30 different documents during the process of transplant assessment. Some of the aspects are now via email, such as the initial referral for transplant listing, and the referral to the transplant centre. However such a mixed economy also incurs governance risks around duplication of work in terms of printing, photocopying and scanning and documents filing. Shared decision making with patients is an increasingly recognised paradigm of renal care 2 . Lee and colleagues reported that shared decision making not only increased the uptake of home dialysis but also led to more live donor transplants 3 . We believe that the traditional model of transplant assessment has considerable shortcomings in this regard. Typically patients will be updated by sending them copies of clinic letters and informing them of decisions for example the decision to list. Barriers to listing and activation on the waiting list, however, are often not clear or transparent to patients 4 . We would suggest that this is particularly true in complex patients, who often have significant comorbidity burden. It is easy to see how this situation can cause uncertainty, confusion and frustration for patients and relatives. From a patient perspective, the transplant assessment process brings with it various significant stressors and takes a considerable emotional toll. This is the case whether a transplant is expected to come from a living or deceased donor, albeit in different ways. As things currently stand, it's commonplace for potential transplant recipients to have contact with a variety of different hospital departments, all of whom are responsible for various aspects of the assessment process. This can often be confusing, particularly if the patient feels as if they are the one inadvertently becoming responsible for "keeping track" of lists of appointments and things to follow up on. Such insecurity may be worsened if there is no holistic approach to care and when patients feel that providers' efforts, however well-meaning, are not co-ordinated. Navigating this is particularly challenging if the assessment is occurring at a time when the patient is also dealing with the increasing physical impact of their kidney disease and with side effects of medication. In this regard chronic fatigue may be particularly relevant and patients often describe "brain fog" during this time. The issue is further compounded by the fact that patients often experience an increasing impact of their condition on lifestyle, work and relationships around the time of transplant assessment. It is therefore not surprising that in a recent study into patient perspectives on the liver transplant waiting list two out of five topics related to coordinating care, namely executing the care plan efficiently, and utilizing interdisciplinary communication and coordination of care 5 . A digital health "roadmap" or record could help with this, provided that it was in a format that was comprehensible. However this would have to be kept up to date as required. If this was offered, but not well executed, it could have a detrimental effect and lead to patients feeling even more confused and ill-informed, leading to the need for additional queries and communication. Another significant issue potential recipients often face during the transplant assessment process is a lack of clarity around what to expect. Communication is vital, and clear 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 6 expectations 5 of what is going to happen and how long it is projected to take go a long way toward allaying patient concerns that they have been forgotten. It is also worth bearing in mind that patients may be experiencing considerable stress during appointments and miss key messages such as the time line for the listing and wait. It would be beneficial if patients were always aware of these time lines, preferably in written or electronic form. This is particularly important if somebody spends a long time waiting for transplant after having been activated on the list, which often occurs in those that are highly sensitised. The issue of transparency and clarity still applies when patients are listed: Studies reported that some patients were unaware of the allocation process 6 or even their status on the waiting list 4 . It is also important to acknowledge that being on the waiting list may in itself be stressful. The psychology of being wait-listed has been described in great detail with hope, constant preparedness and also uncertainty as key emotional factors 7 . Transparency is equally important when, for whatever reason, transplant listing was stopped 4 . An editorialist emphasised that kidney patients encounter difficulties with making decisions about transplantation, as do renal units with informing and supporting these decisions 8 . Another recurring theme in patient feedback, and one that is particularly difficult to achieve for most centres, is the request for continuity of care and for one named clinician as the central point of contact for all queries or concerns. Most patients would also like to see that named care provider semi-regularly. This would provide additional reassurance that transplant assessment is progressing at a reasonable speed 8 . Patients also acknowledge that as a group they vary greatly in their ability and willingness to utilise technology in the content of their medical treatment. Some may prefer information technology and find it easy to navigate, while others may be very hesitant to adopt it or even unable to do so and may find themselves feeling more isolated and "cut off" from their renal team at exactly the time they feel they need consistent support. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 What would the ideal transplant assessment process look like? We propose that transplant teams should view COVID-19 pandemic as a (unique) opportunity to re-think and redesign their pathways for recipient assessment. The fact that recipient assessment is as such a relatively structured pathway should help in this regard ( Figure 2 ). The first major re-think we believe should be around the need for face-to-face assessments. In our institution we rely on a detailed face to face assessment and clinical examination by a physician whereas the surgical review for listing is now often virtual i.e. via video clinic. Only high risk recipients or those with abdominal pathology or obesity are still seen face to face by the surgical team. We feel that this approach is safe and works well as long as physicians and surgeons know and trust each other but we acknowledge that this may be more difficult to achieve in larger centres. A welcome side effect of our approach is that we probably spend slightly less time with straightforward recipients but much more time with complex cases. However, the current percentage of virtual care in transplant assessment is to a large extent borne out of necessity, practicalities and availability of resources during the pandemic but not based on any substantial evidence. We suggest that teams now take the opportunity for conscious and careful reflection on the safe and efficient balance between virtual and face to face assessments. It should also be acknowledged that even experienced clinicians may suffer from unconscious bias hence there is probably benefit if complex and borderline cases or those with high body mass index are always assessed by two clinicians face to face before they are waitlisted or excluded from listing. This will provide additional reassurance to all parties that a balanced and careful decision has been made. Finally we should seek the views of patients and relatives on this important topic. In our experience patients approaching transplantation value face to face time with an experienced clinician even more than before the pandemic. As a transplant community we should therefore ensure that the waitlisting process includes sufficient face to face time. We would encourage teams to seek the views of the patients and relatives on this topic. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 8 A similar rethink has occurred in our approach to review on the waiting list. Many of our follow up appointments early after the initial listing are now virtual, too, especially in younger recipients and those with little or no co-morbidity. Again this has provided us with some extra capacity to schedule additional face to face reviews for high risk recipients, the elderly and those waiting for combined transplants and patients who have waited a long time already. In terms of information technology we believe the time has come for a dedicated cloudbased approach (Figure 2 ). This will have numerous advantages: Firstly, it will bring transplant- It is also important that any cloud-based transplant assessment technology needs to mirror and enable the multi-disciplinary assessment process. As a team we have found the multi-disciplinary approach involving transplant surgeons, coordinators, nephrologists and their specialist nurses, radiologists, and anaesthetists uniquely helpful especially when assessing complex or high risk transplant candidates. All members of the multi-disciplinary team (MDT) need to have access to the information and their contribution must be documented in a way that is accessible and visible to all members of the MDT. Such a cloud-based approach could also help with timetabling, scheduling and documenting MDT meetings and with documenting outcomes and decisions. These, too, need to be transparent and accessible to 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 patients. We also feel it is time to consider patient attendance at such MDT meetings. Based on our experience we feel that a significant proportion of complex and high risk patients would value the option to participate in this crucial part of the decision making regarding transplantation. A bespoke cloud-based system could provide such a facility in a confidential and safe manner and also alert patients when their case is scheduled for decision at an upcoming MDT meeting. Finally, given the widespread practice of recording customer interactions in the corporate world one may consider recording MDT meetings. In the spirit of total transparency patients could, even if the decide not to attend, access a recording of their case discussion and decision making later on if they so wish. Finally, such a cloud based system should also include an option for dialogue with the medical team and links to providers of additional support, such as psychologist or social worker. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 10 Can we go one step further: Which elements of medical assessment are really necessary? A detailed review of all medical aspects of the transplant assessment process is beyond the scope of this article. However, given how constrained access to all aspects of healthcare has been during the pandemic one has to wonder whether all current elements are really essential. As an example, access to myocardial perfusion scans has been severely constrained or nonexistent for much of 2020. Others have recently argued to abandon cardiac screening for asymptomatic transplant candidates 9 . KDIGO guidance currently in draft still suggests that asymptomatic transplant candidates at high risk for coronary artery disease or with poor functional capacity undergo non-invasive screening 10 but there are clearly mounting doubts as to whether the evidence backs this approach. These concerns has been augmented further by the Ischemia-CKD trial and the notion that an interventional strategy in patients with CKD and stable coronary artery disease has no advantage over best medical management 11 . A more definitive answer is expected from the Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates (CARSK) trial (ClinicalTrials.gov NCT03674307) 12 . We believe that the pandemic should make us rethink: Can we really justify delaying the listing process by months in an asymptomatic low risk patient who as a result of the pandemic waits months for a myocardial perfusion scan and where is the evidence to support this approach? This is probably even more appropriate for repeat cardiac investigations in asymptomatic waitlisted patients and also for other investigations for example routine chest imaging. We suggest that physicians and surgeons involved in transplant listing and their teams use the pandemic as an opportunity to reflect more consciously on all elements of the medical assessment and agree on a diagnostic approach that is backed by current evidence, not habit or tradition. Anaesthesia and critical care input into this evolution may also be of signficant benefit. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 One major caveat in redesigning transplant assessment pathways will be the challenge to bridge the "digital divide" 13 . In brief this term describes that all attempts to empower patients by digital means will only ever reach a part of the population which is already quite well engaged whereas another substantial part of the patient population is essentially ignored 14 15 . This pitfall is all the more relevant for the following reasons: Firstly, younger better educated and more IT literate patients and their families are more likely to be aware of service redesign be it via a formal consultation or through social media and networks. Along the same line, this cohort of patients is then more likely to volunteer as patient representatives, participate in discussions around service redesign and thereby influence service development. Finally, enthusiastic clinicians and managers may be biased towards service redesign around enhanced use of technology: Such projects are often perceived as more interesting and likely to attract positive publicity. We suggest that during any service redesign we should ensure good participation from a variety of patients and not just the younger and more IT literate. We should also not lose sight of additional barriers that are often overlooked. A good example is that of transplant candidates who have severe visual impairment. A recent encounter with one such patient prompted us to reflect and record an audio version of our existing brochure for transplant candidates. Similary, we found very little in terms of patient information for patients for whom English is not the first language which made us provide a patient information video in Urdu and Gujarati. We suggest that clinicians proactively seek out feedback from such patient groups and fine tune their approach. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 CONCLUSION The COVID-19 pandemic has been a unique challenge to renal patients and their health care providers. This has included disruption of transplant activity and listing but also affected working patterns and resources more widely. Importantly, we have also lost patients and colleagues to COVID. We do not in any way wish to ignore the suffering and loss caused by the pandemic. However, we argue that the pandemic can also work as a disruptor in a positive sense 16 . Rear Admiral Grace Hopper 17 is credited with the quote that "The most dangerous phrase is 'we've always done it this way. ' We suggest that this also applies to transplant assessment where traditional pathways and practice deserve scrutiny and careful reflection. In the cold light of the post-pandemic dawn much of current practice is based on habit and a risk-averse philosophy 18 but not on robust evidence. We owe our patients an efficient and transparent transplant assessment 19 but much of our own traditional practice is neither. Prompted by our experience during the pandemic we should now rethink the process of transplant listing. Instead of small-step evolutionary service development we should find the courage to define an "ideal" assessment process. Such redesign should not only include the process and information technology aspect but also the diagnostic procedures during the assessment of the transplant candidate. In this regard we should question all elements that are not well supported by current evidence. This process of reflection and service redesign must also involve our patients for whom transplant assessment often occurs at a time of physical decline and emotional upheaval with similar strain on families and loved ones. It is incumbent on us as the transplant community to design an assessment process that is efficient, transparent and well-designed to help us support patients through this uniquely difficult period in their life, nurture their hope 20 and maximise their chances of a successful transplant. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 None declared. The results presented in this paper have not been published previously in whole or part. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 December 16, 2020, at https://www.nytimes.com/1992/01/03/us/rear-adm-grace-m-hopperdies-innovator-in-computers-was-85.html.) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes Shared decision-making in advanced kidney disease: a scoping review protocol Shared Decision Making Increases Living Kidney Transplantation and Peritoneal Dialysis Patient attitudes towards kidney transplant listing: qualitative findings from the ATTOM study Patient Perspectives of High-Quality Care on the Liver Transplant Waiting List: A Qualitative Study Patient preferences, knowledge and beliefs about kidney allocation: qualitative findings from the UK-wide ATTOM programme 8. van der Veer SN, Bekker HL, van Biesen W. How to enhance patient experiences of decision-making about kidney transplantation The Argument for Abolishing Cardiac Screening of Asymptomatic Kidney Transplant Candidates KDIGO Clinical practice guideline on the evaluation and management of candidates for kidney transplantation (in draft) Management of Coronary Disease in Patients with Advanced Kidney Disease Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study Opportunities in the cloud or pie in the sky? Current status and future perspectives of telemedicine in nephrology Access Isn't Enough: Merely Connecting People and Computers Won't Close the Digital Divide Essential Skills for Consumer Health in a Networked World Resetting Healthcare Services During the Coronavirus disease 2019 Pandemic: A Multi-disciplinary Team Approach to Delivering Kidney Transplantation Hopper Dies; Innovator in Computers Was 85. 1992. (Accessed 18. Sharif A. Improving Risk Counseling for Kidney Transplant Candidates Offered Deceased Donor Kidneys Initiating and Completing the Kidney Transplant Evaluation Process: The Red Queen's Race Waiting for a kidney transplant: the experience of patients with end-stage renal disease in South Korea